Arvinas Inc (ARVN) Directors and Executive Officers

Officers & Directors

Executives:

1. John Houston, Ph.D. - President, Chief Executive Officer and Chairman of the Board of Directors
2. Sean Cassidy - Chief Financial Officer and Treasurer
3. David K. Loomis - Vice President and Chief Accounting Officer

Directors:

1. Laurie Smaldone Alsup, M.D.
2. Briggs Morrison, M.D.
3. Everett Cunningham
4. Wendy Dixon, Ph.D.
5. Leslie Norwalk, Esq.
6. Linda Bain
7. Sunil Agarwal, M.D.
8. John Young
9. Edward Kennedy, Jr. ,

Arvinas Inc currently has 246 employees.

News about Arvinas Inc Key Personnel

Arvinas Announces Chief Financial Officer Transition and Records Impressive 215.31% Stock Improvement in the Last 3 Months

Arvinas Inc., a leading biotechnology company specializing in targeted protein degradation, has recently announced the transition of its Chief Financial Officer (CFO), Sean Cassidy, effective February 29, 2024. This significant change in leadership comes at a time when the company has witnessed remarkable growth and success, as evidenced by the impressive 215.31% improvement in its stock value over the past three months.
Sean Cassidy, who has been an instrumental figure in Arvinas financial operations, has decided to part ways with the company. His departure marks the end of an era, as he has contributed immensely to Arvinas growth and has played a key role in the company s financial strategy...

Arvinas Bolsters Legal Team, Appoints Jared Freedberg as General Counsel and Grants Inducement Package in Compliance with Nasdaq Listing Rule 5635(c)(4)

Arvinas Inc., a leading biopharmaceutical company specializing in targeted protein degradation, has taken significant steps to strengthen its legal capabilities with the appointment of Jared Freedberg as General Counsel. In recognition of his expertise and to align with regulatory requirements, the company has also awarded Mr. Freedberg an inducement grant in accordance with Nasdaq Listing Rule 5635(c)(4).
With a commitment to driving innovation through its unique PROTAC® platform, Arvinas has experienced tremendous growth in recent years. Understanding the importance of having strong legal guidance to navigate the complexities of the biopharmaceutical industry, the company has strategically appoi...